South & Central America Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Historic Data: 2021-2022   |   Base Year: 2024   |   Forecast Period: 2024-2031

Report Coverage:
  • Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, Others)
  • Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, Others)
  • Source (Pluripotent Stem Cells, Organ Specific Adult Stem Cell)

No. of Pages: 123
Report Code: BMIRE00032027
Category: Life Sciences
South & Central America Organoids Services Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Organoids Services Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Organoids Services Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Organoids Services Market Regional Analysis

6.2 South & Central America Organoids Services Market Revenue 2021-2031 (US$ Million)
6.3 South & Central America Organoids Services Market Forecast Analysis

7. South & Central America Organoids Services Market Analysis – by Type

7.1 Intestine
  • 7.1.1 Overview
  • 7.1.2 Intestine: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
  • 7.2.1 Overview
  • 7.2.2 Liver: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
  • 7.3.1 Overview
  • 7.3.2 Stomach: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
  • 7.4.1 Overview
  • 7.4.2 Pancreas: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
  • 7.5.1 Overview
  • 7.5.2 Lung: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
  • 7.6.1 Overview
  • 7.6.2 Brain: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
  • 7.7.1 Overview
  • 7.7.2 Kidney: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
  • 7.8.1 Overview
  • 7.8.2 Others: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Organoids Services Market Analysis – by Application

8.1 Developmental Biology Disease
  • 8.1.1 Overview
  • 8.1.2 Developmental Biology Disease: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
  • 8.2.1 Overview
  • 8.2.2 Pathology of Infectious Disease: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
  • 8.3.1 Overview
  • 8.3.2 Regenerative Medicine: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity & Efficacy Testing
  • 8.4.1 Overview
  • 8.4.2 Drug Toxicity & Efficacy Testing: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery & Personalized Medicine
  • 8.5.1 Overview
  • 8.5.2 Drug Discovery & Personalized Medicine: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Organoids Services Market Analysis – by Source

9.1 Pluripotent Stem Cells
  • 9.1.1 Overview
  • 9.1.2 Pluripotent Stem Cells: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
  • 9.2.1 Overview
  • 9.2.2 Organ Specific Adult Stem Cell: South & Central America Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Organoids Services Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America
  • 10.2.1 South & Central America Organoids Services Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.2.1.1 South & Central America Organoids Services Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Brazil: South & Central America Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Brazil: South & Central America Organoids Services Market Breakdown, by Type
    • 10.2.1.1.2 Brazil: South & Central America Organoids Services Market Breakdown, by Application
    • 10.2.1.1.3 Brazil: South & Central America Organoids Services Market Breakdown, by Source
  • 10.2.1.2 Argentina: South & Central America Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 Argentina: South & Central America Organoids Services Market Breakdown, by Type
    • 10.2.1.2.2 Argentina: South & Central America Organoids Services Market Breakdown, by Application
    • 10.2.1.2.3 Argentina: South & Central America Organoids Services Market Breakdown, by Source
  • 10.2.1.3 Rest of South and Central America: South & Central America Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 Rest of South and Central America: South & Central America Organoids Services Market Breakdown, by Type
    • 10.2.1.3.2 Rest of South and Central America: South & Central America Organoids Services Market Breakdown, by Application
    • 10.2.1.3.3 Rest of South and Central America: South & Central America Organoids Services Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 CUSABIO TECHNOLOGY LLC
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Cyprio
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eurofins Scientific SE
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 HUB Organoids B.V. (Hubrecht Organoid Technology)
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 InnoSer
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 InSphero
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 LABTOO
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Molecular Devices, LLC.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Oncodesign Services
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Sino Biological Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - South & Central America Organoids Services Market

  • CUSABIO TECHNOLOGY LLC
  • Cyprio
  • Eurofins Scientific SE
  • HUB Organoids B.V. (Hubrecht Organoid Technology)
  • InnoSer
  • InSphero
  • LABTOO
  • Molecular Devices, LLC.
  • Oncodesign Services
  • Sino Biological Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)